Keyphrases
5′-untranslated Region (5′-UTR)
100%
Differential Sensitivity
100%
NS5A Inhibitor
100%
Protease Inhibitors
100%
Recombinant
100%
NS5A
100%
Hepatitis C Virus Genotypes
100%
Hepatitis C Virus
40%
Direct-acting Antivirals
40%
Virus
30%
NS3/4A Protease
30%
Genotype 1
20%
Boceprevir
20%
Genetic Parameters
20%
Telaprevir
20%
JFH1
20%
NS5B
20%
Huh7.5 Cells
20%
Drug Target
10%
Vaniprevir
10%
Viral
10%
Culture System
10%
NS4A
10%
High Potency
10%
Virus Strains
10%
Preclinical Evaluation
10%
Response Profiles
10%
3′-untranslated Region (3′-UTR)
10%
Concentration-response
10%
Concentration-dependent
10%
Virus Genotype
10%
AIMS™
10%
Immunology and Microbiology
5' Untranslated Region
100%
Hepatitis C Virus
100%
Hepatitis C Virus Genotype 1
100%
NS5A
100%
NS5A Inhibitors
100%
Virus
80%
Untranslated Region
60%
Boceprevir
40%
Recombinant Virus
40%
NS5B
40%
Telaprevir
40%
Concentration Response
20%
Virotherapy
20%
Hepatitis C Virus Genotype 5
20%
Simeprevir
20%
Virus Strain
20%
NS4A
20%
Pharmacology, Toxicology and Pharmaceutical Science
Nonstructural Protein 5A Inhibitor
100%
Hepatitis C Virus Genotype 1
100%
Proteinase Inhibitor
100%
Recombinant
100%
Hepatitis C Virus
50%
Proteinase
20%
Antivirus Agent
20%
Boceprevir
20%
Telaprevir
20%
Daclatasvir
20%
Antiviral Drug
20%
Virotherapy
10%
Vaniprevir
10%
Hepatitis C Virus Genotype 5
10%
Simeprevir
10%
Helicase
10%
Asunaprevir
10%
H 77
10%
Virus Strain
10%